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Abstract
Study sample size in prospective birth cohorts of prenatal exposure to persistent organic pollutants 
(POPs) is limited by costs and logistics of follow-up. Increasing sample size at the time of health 
assessment would be beneficial if predictive tools could reliably back-extrapolate prenatal levels 
in newly enrolled children. We evaluated the performance of three approaches to back-extrapolate 
prenatal levels of p,p′-dichlorodiphenyltrichloroethane (DDT), p,p′-
dichlorodiphenyldichloroethylene (DDE) and four polybrominated diphenyl ether (PBDE) 
congeners from maternal and/or child levels 9 years after delivery: a pharmacokinetic model and 
predictive models using deletion/substitution/addition or Super Learner algorithms. Model 
performance was assessed using the root mean squared error (RMSE), R2, and slope and intercept 
of the back-extrapolated versus measured levels. Super Learner outperformed the other approaches 
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with RMSEs of 0.10 to 0.31, R2s of 0.58 to 0.97, slopes of 0.42 to 0.93 and intercepts of 0.08 to 
0.60. Typically, models performed better for p,p′-DDT/E than PBDE congeners. The 
pharmacokinetic model performed well when back-extrapolating prenatal levels from maternal 
levels for compounds with longer half-lives like p,p′-DDE and BDE-153. Results demonstrate the 
ability to reliably back-extrapolate prenatal POP levels from maternal levels 9 years after delivery, 
with Super Learner performing best based on our fit criteria.
Graphical abstract
INTRODUCTION
Several persistent organic pollutants (POPs), including p,p′-dichlorodiphenyltrichloroethane 
(DDT), p,p′-dichlorodiphenyldichloroethylene (DDE), and polybrominated diphenyl ethers 
(PBDEs) are routinely detected in maternal blood during pregnancy, cord blood, breast milk 
and child blood1, 2. The insecticide p,p′-DDT, which degrades into its more persistent 
metabolite p,p′-DDE, has been widely used in the USA until the 1970’s, and to fight malaria 
in Mexico until 2000. Today, its use is restricted to vector control under the Stockholm 
Convention on POPs. Penta- and octa-PBDEs are flame retardant commercial mixtures that 
were added to upholstered furniture, mattresses, and other consumer items3, but were phased 
out in 2004 in the USA. Many epidemiologic studies have reported associations between 
prenatal exposure to these contaminants and adverse health effects in children4–8.
The prenatal and early life periods are critical windows of susceptibility because many 
systems undergo major structural and functional changes, which, if perturbed by chemicals, 
may alter normal development9, 10. It is therefore crucial to adequately characterize 
exposure during these windows of susceptibility for use in epidemiological studies. 
Biomarkers of prenatal exposure (e.g., maternal blood levels during pregnancy or cord blood 
levels at delivery) can be collected in the context of prospective birth cohort studies. 
However, the sample size of these studies is often restricted due to the costs and logistics of 
follow-up, thereby limiting their statistical power. A solution to this problem would be to 
recruit additional children at the time of health assessment and to back-extrapolate their 
prenatal exposure levels based on measurements later in life.
Different approaches have been used to back-extrapolate levels of lipophilic POPs. Karmaus 
et al.11 evaluated two exponential decay models12, 13 and a linear regression model to back-
extrapolate polychlorinated biphenyl (PCB) levels in non-pregnant women whose blood was 
sampled ~10 years apart. Based on intraclass correlation coefficients (ICCs), they concluded 
that when repeated measurements are available, regression models provide the most accurate 
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estimations (ICCs: 0.77–0.89). However, regression models without cross-validation may 
lead to overfitting of the data and not predict well on new datasets14, 15. This problem can be 
avoided by using machine learning methods such as the deletion/substitution/addition 
(DSA)16 or Super Learner algorithms17, which optimize predictive models based on cross-
validation techniques. In addition, pharmacokinetic models, using prior knowledge of 
physiology and biochemistry, allow for the back-extrapolation of prenatal exposures without 
the risk of overfitting18.
In the present study, we evaluate a life-course pharmacokinetic model and predictive models 
using DSA or Super Learner algorithms to back-extrapolate prenatal levels of p,p′-DDT/E 
and PBDEs (2,2′,4,4′-tetrabromodiphenyl ether [BDE-47], 2,2′,4,4′,5-pentabromodiphenyl 
ether [BDE-99], 2,2′,4,4′,6-pentabromodiphenyl ether [BDE – 100] and 2,2′,4,4′,5,5′-
hexabromodiphenyl ether [BDE – 153]) from maternal and/or child serum levels measured 
9-years after delivery. We compare and contrast these models and make recommendations 
about the best approach.
EXPERIMENTAL
Study population
The Center for the Health Assessment of Mothers and Children of Salinas (CHAMACOS) is 
a longitudinal birth cohort study investigating the health effects of pesticides and other 
environmental contaminants on pregnant women and their children living in the agricultural 
Salinas Valley in California (USA)19. 601 pregnant women were enrolled in the 
CHAMACOS cohort between 1999 and 2000, with the following eligibility criteria: women 
were ≥18 years of age, <20 weeks of gestation, English- or Spanish-speaking, eligible for 
Medi-Cal (subsidized health care), and planning to deliver at Natividad Medical Center. A 
total of 337 CHAMACOS mothers and children were seen between April 2009 and March 
2010 when the children were ~9 years of age. Written informed consent was obtained from 
mothers and children provided verbal assent at 9 years of age. Study activities were 
approved by the Institutional Review Board at the University of California, Berkeley; it was 
determined at the Centers for Disease Control and Prevention (CDC) that the agency was 
not engaged in human subjects research.
For the present study, we conducted analyses on three study population subsets with 
maternal blood collected at ~26 weeks of pregnancy: 1) maternal blood was also collected 9 
years after delivery (n=94), 2) child blood was also collected 9 years after delivery (n=161), 
and 3) both maternal and child blood were collected 9 years after delivery (n=89). Because 
the main aim of the 9-year assessments in the CHAMACOS study was to assess the effects 
of PBDEs and p,p′-DDT/E exposure on growth, pubertal development and 
neurodevelopment in girls, blood was only drawn from mothers whose child was a girl 
(subsets 1 and 3).
Data collection
Study visits occurred twice during pregnancy (at ~13 and 26 weeks gestation), after 
delivery, and when the children were 0.5, 1, 2, 3.5, 5, 7, and 9 years old. Information 
collected included parity, history of breastfeeding, age, residential history, socio-
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demographic factors, and anthropometrics. Birth weight, gestational age, and, gestational 
weight gain were abstracted from maternal medical records. Missing values (<10% missing) 
were imputed at random based on the observed probability distributions of each variable. 
Only maternal and child fat percentage had more than 10% of values missing, with those 
values imputed using a linear regression model with body mass index (BMI) and weight as 
the independent variables.
Laboratory measurements of p,p′-DDT/E and PBDE in serum
Blood samples were collected by venipuncture and stored at -80°C until analyzed for several 
environmental contaminants including p,p′-DDT, p,p′-DDE, BDE-47, BDE-99, BDE-100, 
and BDE-153 at the CDC using gas chromatography isotope dilution high-resolution mass 
spectrometry20. Serum levels were expressed on a serum lipid basis (ng/g lipids); total 
serum lipid concentrations were estimated based on the measurements of triglycerides and 
total cholesterol using standard enzymatic methods (Roche Chemicals, Indianapolis, IN)21. 
For levels <LOD, we used values generated by the instrument when available. When no 
signal was detected, levels <LOD were assigned a value of LOD/√222, an approach that was 
shown to be suitable when the percentage of levels <LOD is 10% or lower23.
Prediction Models
DSA16 and Super Learner17 algorithms were employed for selecting predictive models for 
prenatal p,p′-DDT/E and PBDE levels. The DSA algorithm is a loss-based cross-validation 
method that systematically selects the best predictive model by testing multiple covariate 
combinations, polynomial transformations, and interaction terms. An advantage of the DSA 
algorithm is that the final model outputs the significant predictors and coefficient terms 
within an interpretable parametric model. Super Learner is an ensemble machine learning 
technique that utilizes a weighted combination of algorithms to return a prediction function 
that minimizes a cross-validated loss function, avoiding selecting a single prediction method 
a priori.
For both the DSA and Super Learner algorithms, we used 10-fold cross validation to 
minimize the mean squared error (MSE). To reduce the influence of outliers, serum 
concentrations were log10 transformed. For the DSA algorithm, we allowed second-order 
polynomials and 2-level interactions. For the Super Learner algorithm, we selected a diverse 
group of learning algorithms as potential candidates including: generalized linear model 
(GLM), generalized additive model (GAM), random forest, recursive partitioning and 
regression trees, elastic net, neural network, local polynomial regression, polynomial spline 
regression, Bayesian linear model, support vector machine, and DSA algorithm. In addition 
to fitting GLM, GAM, and Bayesian linear models with all potential predictors, we 
employed a screener prior to use by Super Learner, with the models only using predictors 
significantly correlated with prenatal serum levels in bivariate analysis (p-value ≤ 0.1). 
Algorithm-specific MSEs and weights for each subset are presented in the Table S1 
(Supplemental Information).
Variables considered in the Super Learner and DSA algorithms (expressed as shown in 
Table 1) included maternal characteristics at child birth: number of years lived in the USA, 
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country of birth, education, marital status, age, number of children before index child, and 
breastfeeding duration prior to index child; maternal characteristics 9 years after delivery: 
family income, age at blood draw, breastfeeding duration for children born after index child, 
number of children born after index child, BMI, weight, and fat percentage; and child 
characteristics at 9 years of age: if the child ever lived outside the USA, exact age at blood 
draw, age- and sex-specific BMI z-score based on data from the CDC24, weight, and fat 
percentage. Additional variables collected at the 9-year home visit were considered in PBDE 
analyses: stuffed furniture in home (yes/no and number of pieces of furniture), wall-to-wall 
carpet (yes/no and number of rooms), ripped/torn furniture (yes/no), number of televisions at 
home, and computer at home (yes/no). All compounds within the same class were 
considered for the back-extrapolation of prenatal levels of individual compounds, i.e., 9-year 
p,p′-DDE and p,p′-DDT levels were potential predictors in models of prenatal p,p′-DDE and 
p,p′-DDT, and 9-year levels of all PBDE congeners were potential predictors in models of 
individual PBDE congener prenatal levels.
We used available statistical packages to implement DSA and Super Learner algorithms in 
R, version 3.0.1 (R Foundation for Statistical Computing, Vienna, Austria).
Pharmacokinetic modeling
We used a previously published pharmacokinetic model for POPs18 to back-extrapolate 
prenatal levels of p,p′-DDT/E and PBDEs from 9-year maternal or child levels. This two-
compartment model simulates mother’s lifetime environmental exposure and child exposure 
through transplacental diffusion, breastfeeding and environmental exposure (Figure 1). We 
assumed that p,p′-DDT/E and PBDEs distribute homogeneously across maternal and child 
body lipids, including serum and breast milk lipids. Published half-lives were used to 
describe elimination from the maternal and child compartments. For p,p′-DDT/E, we used 
the same half-lives that were used for model validation18: 5-year half-life for p,p′-DDT25 
and a 13-year half-life for p,p′-DDE26. We used PBDE half-lives calculated by Trudel et 
al.27 using a pharmacokinetic model and human data on daily intakes and PBDE levels in 
lipids: 1.4 years for BDE-47, 0.8 year for PBDE-99, 1.8 years for BDE-100 and 7.4 years 
for BDE-153. To back-extrapolate prenatal levels from maternal or child serum levels at the 
9-year assessment, we modified the pharmacokinetic model to account for the delivery and 
breastfeeding of children born after the index child. Also, we modified the model to account 
for different levels in Mexico and the USA: p,p′-DDT/E exposure is higher in Mexico and 
PBDE exposure is higher in California as indicated by blood levels measured in 
CHAMACOS Mexican-American children born in the USA and Mexican children whose 
mothers are from the same region in Mexico as the CHAMACOS mothers28. We 
approximated that p,p′-DDT/E blood concentrations are 4 times higher in Mexico than in the 
USA and that PBDE concentrations are 7 times higher in the USA than in Mexico based on 
ratios of geometric mean serum levels of p,p′-DDT (parent compound) and BDE-47 
(predominant PBDE congener)28.
To simulate subject-specific exposure profiles, the model incorporated information on 
mothers (years in the USA, timing of prenatal blood draw, gestational weight gain, age at 
delivery, age at subsequent deliveries and duration of breastfeeding of each child born after 
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the index child, pre-pregnancy body weight, age at 9-year blood draw, weight at 9-year 
blood draw) and children (sex, gestational age at birth, birth weight, weight at 9-year blood 
draw, duration of exclusive and total breastfeeding). Using the model inputs mentioned 
above, we estimated the maternal daily dose (ng/kg body weight) by running the model 
iteratively and optimizing the dose to obtain matching simulated and measured serum levels 
at 9 years. In addition to exposure through transplacental diffusion and breastfeeding, 
children are exposed to these compounds in their environment. Because exposure to p,p′-
DDT/E is assumed to occur mostly through food intake, we assumed that after the first year 
of life, children were exposed to the same daily dose of p,p′-DDT/E on a body weight basis 
(ng/kg body weight) as that optimized for the mother. We assumed child environmental 
exposure to PBDEs to be the same absolute daily PBDE dose (ng) as that optimized for the 
mother’s based on similar exposure estimates in Lorber29. Model simulations were carried 
out using acslX (Aegis Technologies Group, Inc., Hunstville, AL, USA).
Assessment of model fit
For each chemical and population subset, we assessed the performance of the different 
models by comparing predicted and measured concentrations. We computed the root MSE 
(RMSE) as our main performance criteria because it quantifies both precision and 
accuracy30, and deconstructed the measure into its two components: precision and accuracy. 
We assessed precision using the R2 statistic and accuracy by evaluating the intercept and 
slope of the linear model between measured and back-extrapolated levels. While a higher R2 
indicates better precision, a slope of 1 and intercept of 0 suggest good accuracy and absence 
of bias. In addition, ICCs were calculated for comparison with results from Karmaus et al.11.
RESULTS
Study participants and Exposure Characteristics
At the index child’s birth, the median maternal age was 26.3 years and mothers had lived in 
the USA for a median of 4.5 years (Table 1). The median breastfeeding time was 7 months 
for the index child and a total of 5 months for subsequent children (including exclusive and 
partial breastfeeding). Median p,p′-DDT/E levels were lower in 9-year child and maternal 
samples than in maternal samples during pregnancy. On the other hand, PBDE were higher 
in 9-year samples than prenatal samples. At 9 years, children’s PBDE levels were about 2 
times higher than maternal levels.
Prediction using the 9-year maternal serum subset
In the subset of participants with maternal serum levels at the 9-year visit (n=94), the Super 
Learner algorithm performed best for all compounds (RMSEs ranging from 0.12 to 0.31), 
followed by DSA (RMSEs ranging from 0.16 to 0.35) and pharmacokinetic modeling 
(RMSEs ranging from 0.21 to 0.59) (Table 2 and Figure 2). For the Super Learner 
algorithm, the R2s ranged from 0.58–0.95, slopes ranged from 0.51 to 0.89, intercepts 
ranged from 0.08 to 0.38 and ICCs ranged from 0.71 to 0.97. Highest model performance 
was observed for back-extrapolated p,p′-DDE and BDE-153 levels, the compounds with the 
longest half-lives. The DSA algorithm selected different sets of predictors depending on the 
compound (Table 3). Of note, maternal 9-year levels of certain compounds with longer half-
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lives were selected to back-extrapolate prenatal levels of shorter half-life compounds, e.g., 
BDE-153 9-year levels were selected to back-extrapolate BDE-47, BDE-99 and BDE-100 
levels. Using the maternal 9-year levels, the pharmacokinetic model performed well when 
back-extrapolating longer half-life compounds p,p′-DDE and BDE-153 with respective 
RMSEs of 0.21 and 0.28, R2s of 0.88 and 0.57, intercepts of 0.12 and 0.07, slopes of 0.92 
and 0.79 and ICCs of 0.92 and 0.75, respectively. The pharmacokinetic model did not 
perform as well for shorter half-life PBDE congeners (BDE-47 and BDE-99).
Prediction using the 9-year child serum subset
Like in the 9-year maternal serum subset, Super Learner (RMSEs ranging from 0.20 to 0.29) 
outperformed the DSA (RMSEs ranging from 0.28 to 0.46) and pharmacokinetic modeling 
(RMSEs ranging from 0.50 to 1.08) approaches when using child 9-year levels (n=161) 
(Table 2 and Figure S1). For the Super Learner algorithm, the R2s ranged from 0.83–0.95, 
intercepts ranged from 0.16 to 0.60, slopes ranged from 0.42 to 0.79 and ICCs ranged from 
0.70 to 0.92. The DSA algorithm fit models for p,p′-DDT/E, BDE-100, and BDE-153, but 
did not select any of the predictors to back-extrapolate prenatal serum concentrations of 
BDE-47 and BDE-99 and only fit an intercept model at the measured mean prenatal serum 
levels. Using the child 9-year levels, the pharmacokinetic model performed relatively well 
for p,p′-DDE, but the precision was low for PBDE levels (R2s ranging from 0.03 to 0.19).
Prediction using the 9-year maternal and child serum subset
In the subset where both maternal and child 9-year serum were available (n=89), the Super 
Learner and DSA algorithms strongly predicted prenatal p,p′-DDT/E and PBDE serum 
levels (Table 2 and Figure S2). For the Super Learner algorithm, the RMSEs ranged from 
0.10 to 0.28, the R2s ranged from 0.65 to 0.97, intercepts ranged from 0.08 to 0.38, slopes 
ranged from 0.57 to 0.93 and ICCs ranged from 0.76 to 0.98. However, including both 
maternal and child 9-year serum levels only marginally increased Super Learner algorithm 
performance compared to models relying solely on maternal 9-year levels (RMSEs ranged 
from 0.12 to 0.31).
DISCUSSION
We evaluated three approaches to back-extrapolate prenatal levels of four PBDE congeners 
(BDE-47, BDE-99, BDE-100 and BDE-153) and p,p′-DDT/E from measured maternal 
and/or child levels 9-years after delivery. Our results suggest that Super Learner may be the 
best approach. In addition, we found that estimations were better for compounds with longer 
biological half-lives (p,p′-DDT/E and BDE-153) compared to compounds with shorter half-
lives (BDE-47, -99, and -100).
Super Learner performed the best based on our criteria to minimize the MSE and maximize 
the R2 of the back-extrapolated versus measured p,p′-DDT/E and PBDE levels, followed by 
DSA and pharmacokinetic modeling. A drawback to using Super Learner is that the 
resulting ensemble prediction algorithm is less interpretable than single prediction 
algorithms because the final output is the weighted output of each algorithm (14 in this 
study), each with specific equation parameters and predictors. Therefore, the increased 
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performance obtained by combining predictive algorithms comes at the cost of reduced 
interpretability of the overall model. Conversely, the DSA algorithm provides the exact 
cross-validated model used for prediction and is thus more transparent than Super Learner. 
However, the DSA was less accurate than Super Learner and it failed to select a predictive 
model for BDE-47 and BDE-99 in the child 9-year serum subset. Although the Super 
Learner and DSA algorithms performed better than pharmacokinetic modeling, the 
prediction models they generated may be less informative for other populations because they 
are driven by variables that are population-specific, e.g., the time spent in the USA for 
Mexican-Americans in the CHAMACOS study. To apply these approaches to other studies, 
paired measurements of prenatal and postnatal levels are necessary to build the models. In 
contrast, because the pharmacokinetic model was built a priori based on physiology and 
biochemistry, and was not calibrated based on measured prenatal levels, it could be used to 
back-extrapolate prenatal levels in other populations without a training dataset. However, 
this approach only performed relatively well for the longer half-life compounds (p,p′-DDE 
and BDE-153).
There are limited studies to compare how well our models back-extrapolated prenatal levels. 
ICCs in our study using the maternal subset (n=94) ranged from 0.71 to 0.97 for Super 
Learner, from 0.63 to 0.95 for DSA, and from 0.26 to 0.92 for the pharmacokinetic models. 
Results obtained with the Super Learner and DSA algorithms were similar to those obtained 
by Karmaus et al.11 (ICCs: 0.77–0.89) who used regression models to back-extrapolate 
women’s polychlorinated biphenyl (PCB) levels measured 10 years apart, and are likely to 
be more generalizable to other populations due to cross-validation31.
Results presented herein have many implications. Models evaluated in this study could be 
used to back-extrapolate prenatal levels in children enrolled at the time of health assessment 
to increase study sample size. For example, in the CHAMACOS longitudinal birth cohort, 
where 337 mothers-child dyads have been followed from pregnancy up to 9-years after 
delivery19, we recruited 309 additional 9-year-old boys and girls and their mother to 
increase the sample size to 646. The prediction model generated using the Super Learner 
algorithm will be used to back-extrapolate prenatal levels in newly enrolled dyads, which 
will allow assessing the health effects of prenatal exposure in a population almost twice as 
large as the original birth cohort. However, the potential to back-extrapolate levels from 
levels measured many years after delivery relies, at least in part, on the persistence of the 
compounds considered in our study. Back-extrapolating levels of chemicals with shorter 
half-lives (e.g., phthalates, triclosan) over a period of many years is less likely to be 
achievable, unless exposure levels are very stable through time.
Results from the DSA analyses allowed us to identify important predictors of p,p′-DDT/E 
and PBDEs. Studies considering back-extrapolating prenatal levels of these compounds will 
need to collect information on maternal and child weight (including fat percentage when 
possible), parity, breastfeeding duration, residence history and socioeconomic status. 
Another important finding in our study is that levels of certain compounds can be used to 
back-extrapolate levels of other compounds. That holds especially true for compounds that 
are correlated at the time of exposure and have different half-lives, e.g., compounds with 
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longer half-lives like BDE-153 may provide valuable information on past exposure to 
shorter half-life compounds like BDE-47.
Certain limitations of this study ought to be mentioned. Although back-extrapolated levels 
explained a large portion of the variability in measured prenatal levels, the slope and 
intercept of the estimated vs. measured regressions were consistently below 1 and above 0, 
respectively. This is expected given that our models did not fully capture the variability in 
measured prenatal levels and, consequently, the variance of the predicted values was less 
than the variance of the measured values. Another limitation is that children born to mothers 
in the maternal 9-year subset were exclusively girls. We cannot rule out the possibility that 
the accuracy of the models differs by sex. In addition, it is possible that measures of model 
fit were influenced by the reduced analytical precision for levels close or below the limit of 
detection. Nonetheless, our ability to back-extrapolate prenatal levels from maternal 9-year 
levels demonstrates that it will be possible for existing and future epidemiologic studies to 
estimate prenatal levels of p,p′-DDT/E and PBDEs from levels measured years after birth.
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Back-extrapolation using pharmacokinetic modeling. The conceptual representation of the 
pharmacokinetic model is depicted in panel A (reproduced with permission from 
Environmental Health Perspectives). Examples of pharmacokinetic profiles of BDE-47 and 
p,p′-DDE are shown in panel B for a woman who moved from Mexico to the USA at the age 
of 10, gave birth at the age of 25 and breastfed for 6 months.
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Scatterplots of back-extrapolated versus measured prenatal (~26 weeks gestation) serum 
concentrations of p,p′-DDT/E and PBDEs using 9-year maternal serum subset (n=94). Root 
mean squared errors (RMSEs) and correlation coefficients (R2) were calculated comparing 
the linear fit of back-extrapolated and measured log10 serum levels (red line). Black line 
represents perfect back-extrapolation. SL = Super Learner, DSA = Deletion/Substitution/
Addition, and PK = pharmacokinetic model.
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